| scholarly article | Q13442814 |
| P50 | author | Ricky N. Bluthenthal | Q46579977 |
| Thomas J Stopka | Q64481657 | ||
| P2093 | author name string | Richard S Garfein | |
| Elise D Riley | |||
| Chaka Dodson | |||
| Erin N Cooper | |||
| P2860 | cites work | Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 |
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. | Q34028865 | ||
| Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. | Q34196408 | ||
| Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel | Q36144756 | ||
| NIMBY localism and national inequitable exclusion alliances: The case of syringe exchange programs in the United States | Q36319923 | ||
| Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program | Q38473166 | ||
| Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. | Q38547252 | ||
| A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? | Q39470907 | ||
| Pharmacist ambivalence about sale of syringes to injection drug users | Q39638019 | ||
| More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. | Q39638023 | ||
| Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. | Q39638033 | ||
| Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. | Q44457466 | ||
| Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. | Q46215792 | ||
| Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. | Q46322577 | ||
| HIV prevalence estimates--United States, 2006. | Q46880600 | ||
| Syringe exchange programs--United States, 2005. | Q50141845 | ||
| Expanding access to syringes. | Q50987344 | ||
| Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users. | Q52281942 | ||
| Approval of syringe exchange programs in California: results from a local approach to HIV prevention | Q56504559 | ||
| Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City | Q58404493 | ||
| Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002) | Q78683278 | ||
| Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003 | Q79816171 | ||
| P433 | issue | 4 | |
| P921 | main subject | San Francisco | Q62 |
| pharmacy | Q614304 | ||
| P304 | page(s) | 543-552 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Journal of Urban Health | Q15760615 |
| P1476 | title | Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007 | |
| P478 | volume | 87 |
| Q35775265 | A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China |
| Q33977256 | Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. |
| Q30538400 | Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study. |
| Q34980340 | Drug-related deaths and the sales of needles through pharmacies |
| Q36090195 | Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA |
| Q33977300 | Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California |
| Q33956101 | Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists |
| Q40339556 | Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015. |
| Q34941301 | Nonprescription syringe sales: a missed opportunity for HIV prevention in California |
| Q36595859 | Pharmacists and harm reduction: A review of current practices and attitudes |
| Q36910528 | Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010. |
| Q36359796 | Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs |
| Q40083334 | Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley |
| Q33977325 | Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? |
Search more.